» Articles » PMID: 6758527

Vascular Effects of Parathyroid Hormone (PTH)

Overview
Date 1982 Jan 1
PMID 6758527
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

PTH causes dose dependent transient vasodilatation in various vascular beds, specifically renal, coeliac, coronary, but not osseous. It has an acute dose-dependent hypotensive effect in the intact animal which is not mediated by alpha- or beta-adrenergic, cholinergic or histaminergic mechanisms. Aortic medial smooth muscle cells respond to PTH with an increase of cAMP, cGMP and, presumably via protein kinase, with activation of phosphorylase B kinase. The acute vasodilatory effect of PTH is antagonised by indomethacin and diclofenac as well as by ouabain, suggesting that the membrane Na-K pump and prostaglandins are involved in PTH-induced vasodilatation. Parathyroidectomy and a high calcium diet attenuate the rise of arterial pressure in experimental hypertension, pointing to some permissive effect of PTH for development hypertension. This is most likely due to long term effects of PTH on vessel wall calcium content and exchange. This chronic effect of PTH may explain the high prevalence of hypertension in patients with primary hyperparathyroidism.

Citing Articles

Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.

Rejnmark L, Gosmanova E, Khan A, Makita N, Imanishi Y, Takeuchi Y Adv Ther. 2024; 41(6):2500-2518.

PMID: 38691316 PMC: 11133178. DOI: 10.1007/s12325-024-02843-8.


The Endocrine Role of Bone in Cardiometabolic Health.

DeLuccia R, Cheung M, Ramadoss R, Aljahdali A, Sukumar D Curr Nutr Rep. 2019; 8(3):281-294.

PMID: 31297756 DOI: 10.1007/s13668-019-00286-0.


Endothelial function in mild primary hyperparathyroidism.

Carrelli A, Walker M, Di Tullio M, Homma S, Zhang C, McMahon D Clin Endocrinol (Oxf). 2012; 78(2):204-9.

PMID: 22757971 PMC: 3479355. DOI: 10.1111/j.1365-2265.2012.04485.x.


Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism.

Walker M, Rundek T, Homma S, DiTullio M, Iwata S, Lee J Eur J Endocrinol. 2012; 167(2):277-85.

PMID: 22660025 PMC: 3668344. DOI: 10.1530/EJE-12-0124.